TAFRO syndrome was effectively treated with an inexpensive novel scheme: A case report

Abstract

Abstract A man diagnosed as TAFRO syndrome was successfully responded to a novel immunosuppressive regimen containing methylprednisolone and mycophenolate mofetil. Blood cells firstly recovered, followed by the general situation and complete recover 1 month later, highlighting the danger of TAFRO syndrome and the importance of immunosuppressive agents in reversing pathological course.

Keywords

• Castleman disease
• hematology
• immunosuppressive agents
• oncology